Showing results (1121-1130 of 3,178) with videos related to

Sort By:
Pageof 318
Translational Oncology|November 4, 2022
DKK1 as a robust predictor for adjuvant platinum chemotherapy benefit in resectable pStage II-III gastric cancerZhiyuan Fan, Beiqin Yu, Tao Pan, et al.
Translational Oncology|November 4, 2022
MicroRNAs and long non-coding RNAs in pancreatic cancer: From epigenetics to potential clinical applicationsLuis Alberto Bravo-Vázquez, Natalia Frías-Reid, Ana Gabriela Ramos-Delgado, et al.
Translational Oncology|October 24, 2022
Tetramer-aided sorting and single-cell RNA sequencing facilitate transcriptional profiling of antigen-specific CD8+ T cellsKamalakannan Rajasekaran, Xiangnan Guan, Alireza Tafazzol, et al.
Translational Oncology|September 6, 2022
Evaluation of PD-L1 expression in a large set of gastroenteropancreatic neuroendocrine tumours and correlation with clinicopathological dataErik Rösner, Daniel Kaemmerer, Jörg Sänger, et al.
Translational Oncology|October 11, 2022
Impact of baseline telomere length on survival and chemotherapy related toxicity in breast cancer patients receiving (neo)adjuvant anthracycline containing chemotherapySigrid Hatse, Marta Serena, Christof Vulsteke, et al.
Translational Oncology|September 16, 2022
Energy metabolism pathways in breast cancer progression: The reprogramming, crosstalk, and potential therapeutic targetsXuewei Zheng, Haodi Ma, Jingjing Wang, et al.
Translational Oncology|September 14, 2022
Current perspectives on interethnic variability in multiple myeloma: Single cell technology, population pharmacogenetics and molecular signal transductionManav Gandhi, Viral Bakhai, Jash Trivedi, et al.
Translational Oncology|September 17, 2022
Higher serum sPD-L1 levels after radiotherapy indicate poor outcome in hepatocellular carcinoma patientsYang Zhang, Zongjuan Li, Yixing Chen, et al.
Translational Oncology|September 20, 2022
Ra-223 induces clustered DNA damage and inhibits cell survival in several prostate cancer cell linesAndris Abramenkovs, Mehran Hariri, Diana Spiegelberg, et al.
Translational Oncology|September 19, 2022
Why the complications of COVID-19 patients differ in elderly and young cancer patientsSara Bravaccini, Fabio Nicolini, Michele Zanoni, et al.
Pageof 318